VOR

8.18

1.51% -0.125

Handel nachbörslich: 8.18

Vor Biopharma Inc (VOR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.305

Offen:

$8.43

24-Stunden-Volumen:

245.16K

Relative Volume:

0.41

Marktkapitalisierung:

$179.23M

Einnahmen:

Nettoeinkommen (Verlust:

$-112.46M

KGV:

-4.9878

EPS:

-1.64

Netto-Cashflow:

$-99.89M

1W Leistung:

-1.80%

1M Leistung:

-60.88%

6M Leistung:

+82.92%

1J Leistung:

-51.60%

1-Tages-Spanne:

$7.91

$8.43

1-Wochen-Bereich:

$7.21

$8.60

52-Wochen-Spanne:

$2.622

$65.80

Vor Biopharma Inc Stock (VOR) Company Profile

Firmenname

Vor Biopharma Inc

Sektor

Healthcare (1132)

Branche

Biotechnology (632)

Telefon

617-655-6580

Adresse

500 BOYLSTON STREET, BOSTON

Mitarbeiter

168

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

VOR's Discussions on Twitter

Vergleichen Sie VOR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VOR Vor Biopharma Inc	8.18	182.52M	0	-112.46M	-99.89M	-1.64
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-25	Fortgesetzt	Wedbush	Neutral
2025-10-15	Hochstufung	Robert W. Baird	Neutral → Outperform
2025-09-24	Hochstufung	Stifel	Hold → Buy
2025-06-30	Hochstufung	H.C. Wainwright	Neutral → Buy
2022-07-26	Eingeleitet	Wedbush	Outperform
2022-04-27	Eingeleitet	Goldman	Neutral
2021-12-17	Eingeleitet	H.C. Wainwright	Buy
2021-12-03	Eingeleitet	Robert W. Baird	Outperform
2021-12-02	Eingeleitet	Oppenheimer	Outperform
2021-10-19	Eingeleitet	JMP Securities	Mkt Outperform
2021-03-25	Eingeleitet	B. Riley Securities	Buy
2021-03-03	Eingeleitet	Barclays	Overweight
2021-03-03	Eingeleitet	Evercore ISI	Outperform
2021-03-02	Eingeleitet	Goldman	Sell
2021-03-02	Eingeleitet	Stifel	Buy

Alle ansehen

Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten

Dec 03, 2025

Will Vor Biopharma Inc. stock maintain momentum in 2025Gold Moves & Capital Efficiency Focused Strategies - Newser

Dec 03, 2025

What drives Vor Biopharma Inc stock priceEarnings Surprise Analysis & Superior Capital Trading Plans - earlytimes.in

Dec 03, 2025

Dec 02, 2025

Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? - Yahoo Finance

Dec 02, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 02, 2025

Dec 01, 2025

Form 424B3 Vor Biopharma Inc. - StreetInsider

Dec 01, 2025

Nov 28, 2025

Wedbush Predicts Vor Biopharma's Q4 Earnings (NASDAQ:VOR) - MarketBeat

Nov 28, 2025

Nov 26, 2025

How Vor Biopharma Inc. stock benefits from global expansionLayoff News & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ

Nov 26, 2025

Wedbush Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat

Nov 26, 2025

Nov 25, 2025

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 25, 2025

Wedbush Initiates Coverage on Vor Biopharma (VOR) with Neutral R - GuruFocus

Nov 25, 2025

Wedbush Boosts Price Target on Vor Biopharma to $9 From $0.40, Keeps Neutral Rating - MarketScreener

Nov 25, 2025

Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral - StreetInsider

Nov 25, 2025

Nov 21, 2025